James Healy
Sits on 6 boards. Overboarded · 6 public boards Last updated September 27, 2026
Time on boards
- Boards served
- 6
- Current seats
- 6
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 6 boards, counting each seat separately. Longest: Natera Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ArriVent BioPharma Inc. June 18, 202661.0%
-
BioAge Labs Inc. June 10, 202681.6%
-
Rapport Therapeutics Inc. June 10, 202698.6%
-
Bolt Biotherapeutics Inc. June 12, 202378.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Seaport Therapeutics Inc. | Derivative conversion | +1,927,159 | — | — |
| May 4, 2026 | Seaport Therapeutics Inc. | Derivative conversion | +804,379 | — | — |
| Apr 25, 2025 | Natera Inc. | Grant or award | +142 | — | — |
| Jan 31, 2025 | Natera Inc. | Grant or award | +114 | — | — |
| Oct 25, 2024 | Natera Inc. | Grant or award | +153 | — | — |
| Sep 27, 2024 | BioAge Labs Inc. | Derivative conversion | +1,638,236 | — | — |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +588,888 | $18.00 | $10,599,984 |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +11,113 | $18.00 | $200,034 |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +18,353 | $18.00 | $330,354 |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +21,814 | $18.00 | $392,652 |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +26,497 | $18.00 | $476,946 |
| Jul 26, 2024 | Natera Inc. | Grant or award | +177 | — | — |
| Jul 1, 2024 | Rapport Therapeutics Inc. | Open-market purchase | +3,538 | $23.08 | $81,657 |
| Jul 1, 2024 | Rapport Therapeutics Inc. | Open-market purchase | +3,565 | $24.21 | $86,309 |
| Jul 1, 2024 | Rapport Therapeutics Inc. | Open-market purchase | +4,544 | $25.02 | $113,691 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.